Atlas Trials

Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer

Clinical trial NCT01044485 · COMPLETED

Trial details

NCT number
NCT01044485
Sponsor
Centre Georges Francois Leclerc
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2008-11-01
Primary completion
2011-11-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.